Preexisting antiviral antibodies in cancer patients can quickly neutralize oncolytic measles virus (MV) and decrease its antitumor potency. In contrast to naked viruses, cell- associated viruses are protected from antibody neutralization,” researchers in the United States report. Source: General Cancer News Articles Provided by Cancer Compass